Firms focused on drug discovery, genetic research, and life sciences.
Theme Performance
Equal-weight basket of constituents
1 Day
-2.14%
1 Week
-3.16%
1 Month
+7.68%
3 Months
+14.79%
Year to Date
+7.04%
Constituents
15 active symbols
| Ticker | Company | Market Cap | Price | 1D % | 1W % | 1M % | 3M % | YTD % |
|---|---|---|---|---|---|---|---|---|
| Amgen Inc | $184.096B | $343.9850 | -0.31% | -0.83% | +4.01% | +17.17% | +4.35% | |
| Gilead Sciences Inc | $176.114B | $143.2400 | +1.72% | +4.43% | +15.24% | +19.79% | +16.74% | |
| Vertex Pharmaceuticals Inc | $119.222B | $471.5600 | -1.22% | +0.32% | +3.56% | +12.63% | +3.93% | |
| Regeneron Pharmaceuticals Inc | $78.943B | $761.2900 | -1.07% | -1.61% | -4.20% | +13.56% | -4.49% | |
|
A
ARGX
|
argenx SE American Depositary Shares | $52.013B | $845.2600 | -0.85% | +3.16% | +0.31% | +2.25% | +0.06% |
| Alnylam Pharmaceuticals, Inc. | $44.662B | $338.0950 | -2.52% | -5.56% | -14.90% | -29.80% | -15.52% | |
|
B
BNTX
|
BioNTech SE American Depositary Share | $28.543B | $108.8200 | -2.59% | -1.92% | +19.39% | +10.06% | +17.64% |
| Biogen Inc. Common Stock | $26.390B | $179.7300 | +2.11% | +4.84% | +1.98% | +21.66% | +1.16% | |
| Illumina Inc | $22.127B | $141.9100 | -3.26% | -3.64% | +9.08% | +52.38% | +7.79% | |
| Incyte Genomics Inc | $19.646B | $101.2200 | -1.00% | -1.88% | +1.17% | +10.97% | -1.33% | |
| Moderna, Inc. Common Stock | $17.700B | $43.1600 | -5.95% | -9.53% | +44.92% | +78.42% | +42.81% | |
| Jazz Pharmaceuticals, Inc. | $9.995B | $167.6500 | +0.31% | -2.50% | -3.71% | +21.19% | -5.00% | |
| CRISPR Therapeutics AG | $4.761B | $50.5221 | -6.35% | -10.01% | -6.07% | -20.14% | -7.09% | |
| Beam Therapeutics Inc. Common Stock | $2.803B | $27.6150 | -5.70% | -12.48% | -0.72% | +11.51% | +1.77% | |
| Intellia Therapeutics, Inc | $1.523B | $13.1100 | -5.40% | -10.12% | +45.14% | +0.23% | +42.78% |
